Antiviral effects of cranberry juice and cranberry proanthocyanidins on foodborne viral surrogates--a time dependence study in vitro.
Cranberry juice (CJ) and cranberry proanthocyanidins (PAC) are widely known for their antibacterial, antiviral, and pharmacological activities. The effect of CJ and cranberry PAC on the infectivity of foodborne viral surrogates, murine norovirus (MNV-1), feline calicivirus (FCV-F9), MS2 (ssRNA) bacteriophage, and ϕX-174 (ssDNA) bacteriophage after 0 min to 1h at room temperature was evaluated. Viruses at titers of ∼5log(10)PFU/ml were mixed with equal volumes of CJ at pH 2.6, CJ at pH 7.0, 0.30 mg/ml CJ PAC, 0.60mg/ml PAC, or water and incubated for 0, 10, 20, 30, 40, 50 min, and 1h at room temperature. Infectivity was determined using standard plaque assays. The viral reduction rates of the four tested viruses were found to vary considerably. Among the tested viruses, FCV-F9 titers were decreased the most by ∼5log(10)PFU/ml within 30 min. MS2 titers were decreased the least by only ∼1log(10)PFU/ml after 1h with CJ at pH 2.6 and 0.30 mg/ml PAC, and ∼0.5log(10)PFU/ml with CJ at pH 7.0 and 0.15 mg/ml PAC. MNV-1 and ϕ-X174 showed comparable titer reductions which was between that of FCV-F9 and MS2. In most cases, viral reduction within the first 10 min of treatment accounted for ≥50% of the total reduction. Transmission electron microscopy on FCV-F9 treated with CJ and PAC revealed structural changes. This study shows potential of using natural bioactive compounds for controlling foodborne viral diseases. Further studies are necessary to elucidate the mechanism of action of CJ components and to understand the differences in viral titer reduction profiles.
Su
Xiaowei
X
Department of Food Science and Technology, University of Tennessee-Knoxville, Knoxville, TN 37996, USA.
Howell
Amy B
AB
D'Souza
Doris H
DH
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001628:Beverages / Q000032:analysis*; D002415:Cats; D002460:Cell Line; D005517:Foodborne Diseases / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D051379:Mice; D010936:Plant Extracts / Q000494:pharmacology; D044945:Proanthocyanidins / Q000494:pharmacology*; D029799:Vaccinium macrocarpon / Q000737:chemistry*; D038301:Virus Inactivation / Q000187:drug effects; D014780:Viruses / Q000187:drug effects* / Q000254:growth & development
D000998:Antiviral Agents; D010936:Plant Extracts; D044945:Proanthocyanidins